Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Clonidine vs Phenobarbital for Neonatal Abstinence Syndrome
NCT03670160Phase 2Completed
- Sponsor
- University of Tennessee Medical Center
- Start
- Oct 2018
- Primary completion
- May 2020
- Modality
- Small Molecules, Device-based Delivery
- Countries
- 1
01
Overview
A Phase 2 trial of Clonidine Lauriad in neonatal abstinence syndrome (NAS), sponsored by University of Tennessee Medical Center. Started Oct 2018; status: completed.
02
Drugs
Clonidine Lauriad
03
Conditions
neonatal abstinence syndrome (NAS)
Beyond the preview
Go deeper on NCT03670160.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03670160.